Plato Investment Management Ltd Grows Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Plato Investment Management Ltd lifted its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 1,200.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 351 shares of the medical instruments supplier’s stock after purchasing an additional 324 shares during the period. Plato Investment Management Ltd’s holdings in Mettler-Toledo International were worth $467,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Raymond James Financial Services Advisors Inc. grew its position in Mettler-Toledo International by 25.4% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 1,676 shares of the medical instruments supplier’s stock valued at $2,033,000 after acquiring an additional 340 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of Mettler-Toledo International by 31.7% in the 4th quarter. Fifth Third Bancorp now owns 752 shares of the medical instruments supplier’s stock worth $912,000 after acquiring an additional 181 shares during the period. DAVENPORT & Co LLC purchased a new position in Mettler-Toledo International in the fourth quarter worth $997,000. Trust Point Inc. acquired a new position in Mettler-Toledo International during the fourth quarter worth $224,000. Finally, Boston Trust Walden Corp raised its holdings in shares of Mettler-Toledo International by 10.8% in the fourth quarter. Boston Trust Walden Corp now owns 35,015 shares of the medical instruments supplier’s stock worth $42,472,000 after acquiring an additional 3,427 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 6.2 %

Shares of Mettler-Toledo International stock traded down $93.75 on Friday, hitting $1,421.60. 218,471 shares of the company traded hands, compared to its average volume of 145,168. The company has a market cap of $30.37 billion, a P/E ratio of 42.48, a P/E/G ratio of 4.08 and a beta of 1.17. The firm’s 50-day simple moving average is $1,414.93 and its 200 day simple moving average is $1,325.04. Mettler-Toledo International Inc. has a 12-month low of $928.49 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating analysts’ consensus estimates of $9.00 by $0.65. The company had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a negative return on equity of 662.32% and a net margin of 20.55%. The firm’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $10.19 earnings per share. Analysts predict that Mettler-Toledo International Inc. will post 40.13 earnings per share for the current year.

Analysts Set New Price Targets

MTD has been the subject of several research reports. Stifel Nicolaus boosted their price objective on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the stock a “buy” rating in a research note on Monday, May 13th. Robert W. Baird raised their price target on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a “neutral” rating in a report on Monday, May 13th. Jefferies Financial Group reaffirmed an “underperform” rating and issued a $1,250.00 price objective (up previously from $1,230.00) on shares of Mettler-Toledo International in a research note on Monday, June 3rd. The Goldman Sachs Group lifted their target price on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 9th. Finally, StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,301.25.

Insiders Place Their Bets

In other news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $1,457.07, for a total value of $437,121.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $7,160,041.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Christian Magloth sold 1,100 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,470.97, for a total value of $1,618,067.00. Following the completion of the sale, the insider now owns 734 shares in the company, valued at approximately $1,079,691.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $1,457.07, for a total value of $437,121.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $7,160,041.98. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,278 shares of company stock valued at $4,871,849. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.